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Background: Arthritis (compression) gloves are commonly provided to people with 
rheumatoid arthritis (RA) and undifferentiated inflammatory arthritis (IA) in the UK health 
service. These apply pressure and warmth to relieve hand pain, stiffness and improve hand 
function. A systematic review identified little evidence to support their use.1 
Objectives: This randomised controlled trial tested effectiveness and cost-effectiveness of 
mid-finger length compression (intervention) gloves (20% Lycra: commonest glove model 
provided) with control gloves (i.e. oedema gloves: 11% Lycra: fitted at least one size too big) 
in people with RA and IA. 
Methods: Both gloves, which had similar thermal qualities although the control gloves did 
not provide compression, were provided by rheumatology occupational therapists, following 
training.2 Participants were also given brief advice on hand exercise and joint protection. 
Adults with RA/IA and persistent hand pain were randomised 1:1 to the two glove types, 
stratified by disease modifying anti-rheumatic drug (DMARD) change in previous 12 weeks. 
The primary outcome was dominant hand pain on activity Visual Analogue Scale (VAS:0–
10); other outcomes included night hand pain, hand stiffness (both 0–10 VAS); Measure of 
Activity Performance Hand (MAP-HAND: 0–3). Multiple linear regression was undertaken 
to estimate the effect of group allocation on hand pain during activity, adjusting for the 
stratification variable and baseline values. Cost-effectiveness used individual patient level 
costs (intervention plus healthcare utilisation) and health benefit data (EQ-5D) to calculate 
costs and QALYs. 
Results: 206 participants were randomised (103 to each glove type): median age 59 years 
[IQR 51,67]; women:166 (81%); mean disease duration: 8.2 (SD 9.5) years; employed:76 
(37%); right hand dominant:185 (90%). Of these, 163 (79%) completed 12 week follow-up 
questionnaires. Both groups reported similar adherence to glove wear (mean 5.2 days/week). 
At 12 w, hand pain scores in both groups similarly improved: the between-groups mean 
difference of 0.1 was not statistically significant (95% CI: −0.47 to 0.67;p=0.72). There were 
no significant differences between groups on any measures, with both groups improving 
similarly between baseline and 12 w. 73% in both groups considered gloves beneficial. 
Intervention gloves had higher costs (£552 (SD £464); control £391 (SD £543) but 
comparable benefits to control gloves. Intervention gloves would cost £83 700 to gain one 
QALY and were not likely to be cost-effective. 
Conclusions: Compression (intervention) and loose-fitting arthritis (control) gloves had 
similar effects on hand pain, stiffness and function. Therefore, compression is not the ‘active 
ingredient’ in arthritis gloves. Loose fitting gloves providing warmth were perceived as 
equally effective by participants. We do not know if the therapist effect is important or 
whether ordinary gloves providing warmth would provide similar results. 
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